Crohn’s disease

What Is Crohn’s Disease?

Crohn’s disease is a chronic, immune mediated disorder that causes inflammation extending through the full thickness of the intestinal wall, and unlike some related conditions, it can affect any segment of the digestive tract from the mouth to the anus.¹

Crohn’s disease belongs to a broader category of conditions called inflammatory bowel disease, which also includes ulcerative colitis, though the two conditions differ meaningfully in which parts of the digestive tract they affect and how deeply the inflammation extends into the intestinal wall.¹

The exact cause of Crohn’s disease remains unknown, though it appears to develop in genetically susceptible individuals whose immune systems mount an abnormal, exaggerated response to bacteria normally present within the intestines.²

Crohn disease occurs in genetically susceptible individuals who develop aberrant immune responses to bacteria within the intestine, with the resulting inflammatory response mediated through cytokines that promote chronic, transmural inflammation.
National Center for Biotechnology Information

Symptoms

The most common symptoms of Crohn’s disease include diarrhea, abdominal pain, and fever, often accompanied by a sense of urgency and increased frequency of bowel movements.¹

Many patients also experience unintended weight loss and, in some cases, the passage of blood or mucus with bowel movements, reflecting ongoing inflammation and tissue damage within the digestive tract.¹

Because Crohn’s disease can affect any part of the digestive tract, symptoms can vary considerably between patients depending on which segments of the intestine are involved, and episodes of active symptoms often alternate with periods of remission.

Causes

Crohn’s disease develops through a complex disruption of the immune response within the intestinal lining, involving changes to the natural protective barrier of the gut alongside remodeling of surrounding tissue.²

This altered environment promotes immune cell migration into areas of inflammation, driving a specific type of inflammatory response involving cytokines such as interleukin twelve and tumor necrosis factor alpha, both of which contribute to ongoing tissue damage.²

Genetic factors play a meaningful role in disease susceptibility, with variants in certain genes, including one called NOD2, identified as contributing to altered immune responses against intestinal bacteria in people who develop Crohn’s disease.³

Risk Factors

A genetic predisposition toward abnormal immune responses represents a significant risk factor for Crohn’s disease, and the condition frequently runs in families, reflecting this underlying genetic component.³

Active smoking stands out as one of the most well established, modifiable risk factors for developing Crohn’s disease, and it also negatively affects disease progression once diagnosis has occurred.³

Patients who continue smoking after diagnosis face meaningfully worse outcomes, including higher treatment requirements and increased relapse rates, with heavy smokers and women who smoke facing particularly elevated risk of developing severe disease.³

Complications

Repeated cycles of inflammation followed by healing can leave fibrotic scarring within affected segments of intestine, and over time, this scarring can lead to narrowing, called stricture formation, and eventual bowel obstruction.²

Inflammation can also extend beyond the intestine itself to involve nearby organs, occasionally forming abnormal connections called fistulae between the intestine and the bladder, skin, or other nearby structures.²

Despite advances in medical therapy, most patients with Crohn’s disease eventually require surgery at some point during the course of their disease, most commonly to address fibrostenotic complications such as strictures.³

Treatment

Biologic therapies, particularly medications targeting tumor necrosis factor, have proven remarkably effective for controlling severe Crohn’s disease, and many patients remain on this type of therapy for several years as part of long term management.³

Immunosuppressive medications and corticosteroids also play an important role in Crohn’s disease treatment, often used as part of a stepwise approach that escalates therapy based on disease severity and response.³

Surgical resection or a procedure called stricturoplasty may become necessary for patients who develop fibrostenotic complications, and immunosuppressive therapy has been shown to help offset some of the negative surgical risk associated with continued smoking.³

Prevention

Because Crohn’s disease results from a complex interaction between genetic susceptibility and immune dysfunction, there is currently no reliable way to prevent its initial development.

For people already diagnosed, avoiding smoking represents one of the most impactful, modifiable steps available, given its clear association with worse disease progression, higher treatment needs, and increased relapse risk.³

Consistent adherence to prescribed medication, along with regular monitoring by a gastroenterologist, plays an important role in maintaining remission and reducing the risk of complications requiring surgery.

Why Visual Communication Matters for Crohn’s Disease

Explaining how inflammation can extend through the full thickness of the intestinal wall, and why this leads to complications such as strictures and fistulae, requires visuals that make these internal structural changes clear and understandable.

Pharmaceutical companies, gastroenterology practices, and patient education organizations rely on clear illustration and animation to explain Crohn’s disease and support informed treatment decisions.

• Illustrating transmural inflammation and its distinction from other forms of inflammatory bowel disease
• Animating the immune mechanisms driving chronic intestinal inflammation
• Explaining the mechanism of action of biologic and immunosuppressive therapies
• Visualizing stricture formation, fistulae, and other structural complications
• Supporting patient education on smoking cessation and treatment adherence
• Creating training materials for gastroenterology and surgical clinicians

How Biotic Artlab Supports Crohn’s Disease Communication

We work with pharmaceutical companies, gastroenterology practices, and patient advocacy organizations to create accurate, engaging visuals that make Crohn’s disease and its treatment easier to understand.

• Custom 3D animations of transmural intestinal inflammation and immune signaling
• Detailed illustrations of stricture formation, fistulae, and surgical interventions
• Mechanism of action animations for biologic and immunosuppressive therapies
• Patient facing materials on symptom management and treatment adherence
• Clinical training content for gastroenterology and surgical teams
• Conference presentations and marketing visuals for digestive health audiences

Frequently Asked Questions

What is the difference between Crohn’s disease and ulcerative colitis?

Crohn’s disease can affect any part of the digestive tract and causes inflammation through the full thickness of the intestinal wall, while ulcerative colitis is generally limited to the colon and rectum with more superficial inflammation.¹

What causes Crohn’s disease?

The exact cause is unknown, but Crohn’s disease is believed to result from an abnormal immune response to intestinal bacteria in genetically susceptible individuals.²

Does smoking affect Crohn’s disease?

Yes, smoking is a well established risk factor for developing Crohn’s disease and is associated with worse disease progression and higher relapse rates after diagnosis.³

Will I need surgery for Crohn’s disease?

Many patients eventually require surgery, most commonly to address strictures or other structural complications, despite advances in medical therapy.³

What are biologic therapies for Crohn’s disease?

Biologic medications, particularly those targeting tumor necrosis factor, have proven highly effective for controlling severe Crohn’s disease and are commonly used for long term management.³

Is Crohn’s disease hereditary?

Genetic factors meaningfully contribute to risk, and the condition frequently runs in families, though it results from a combination of genetic and immune factors rather than inheritance alone.³

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to Crohn’s disease or inflammatory bowel disease, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Crohn Disease.
2. National Center for Biotechnology Information. Pathophysiology of Crohn’s Disease Inflammation and Recurrence.
3. National Center for Biotechnology Information. Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s Disease.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.